Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipilimumab Dose-Ranging in Advanced Melanoma
NCT00289640Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Apr 2006
- Primary completion
- Jul 2007
- Modality
- Monoclonal Antibodies
- Countries
- 10
01
Overview
A Phase 2 trial of ipilimumab in melanoma, sponsored by Bristol Myers Squibb. Started Apr 2006; status: completed.
02
Drugs
ipilimumab
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00289640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00289640.